Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science Publishers]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zaq完成签到,获得积分10
刚刚
hbpu230701完成签到,获得积分0
2秒前
烂漫映之完成签到 ,获得积分10
2秒前
2秒前
federish完成签到 ,获得积分10
3秒前
Nium完成签到,获得积分10
3秒前
1111完成签到,获得积分10
3秒前
凌氏冯雯完成签到,获得积分10
4秒前
Swear完成签到 ,获得积分10
4秒前
4秒前
无敌通完成签到,获得积分10
5秒前
淡淡的新之完成签到,获得积分10
5秒前
Donger完成签到 ,获得积分10
5秒前
貔貅完成签到,获得积分10
5秒前
Anonymous完成签到,获得积分10
5秒前
6秒前
所所应助linkman采纳,获得10
6秒前
丘比特应助linkman采纳,获得10
6秒前
Maestro_S应助linkman采纳,获得10
6秒前
kk应助linkman采纳,获得50
6秒前
revew666完成签到,获得积分10
6秒前
TCXXS完成签到 ,获得积分10
8秒前
8秒前
Jasper应助000采纳,获得10
8秒前
豚骨大王发布了新的文献求助10
9秒前
9秒前
Luka发布了新的文献求助10
9秒前
开飞机的天天完成签到,获得积分10
10秒前
量子星尘发布了新的文献求助10
10秒前
害羞的裘完成签到 ,获得积分10
11秒前
石头完成签到,获得积分10
11秒前
johnny完成签到,获得积分10
12秒前
junzilan完成签到,获得积分10
12秒前
Fiona完成签到,获得积分10
12秒前
星星会开花完成签到,获得积分10
13秒前
13秒前
科目三应助动感的帅采纳,获得10
14秒前
just完成签到,获得积分10
15秒前
海慕云完成签到,获得积分10
15秒前
yier发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
网络安全 SEMI 标准 ( SEMI E187, SEMI E188 and SEMI E191.) 1000
Inherited Metabolic Disease in Adults: A Clinical Guide 500
计划经济时代的工厂管理与工人状况(1949-1966)——以郑州市国营工厂为例 500
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
The Pedagogical Leadership in the Early Years (PLEY) Quality Rating Scale 410
Why America Can't Retrench (And How it Might) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4613661
求助须知:如何正确求助?哪些是违规求助? 4018221
关于积分的说明 12437528
捐赠科研通 3700870
什么是DOI,文献DOI怎么找? 2040947
邀请新用户注册赠送积分活动 1073711
科研通“疑难数据库(出版商)”最低求助积分说明 957365